The heterogeneity of head and neck squamous cell carcinoma was demonstrated in whole-exome sequencing identifying a small number of activating mutations in oncogenes and highlighting the role of p53, Rb/INK4/ARF and Notch tumor suppressor pathways [18, 21, 22, 41]. Here, CDKN2A is linked to head and neck squamous cell carcinoma.